California jury renders $106.5 million verdict against Medtronic in heart-valve patent case
Share
Tweet
February 10, 2023
Star Tribune
Medtronic's Fridley headquarters.
A federal jury in California said Wednesday that a unit of Medtronic must pay $106.5 million to competitor Colibri Heart Valve LLC for patent infringement.
After a seven-day trial in Santa Ana, Calif., the jury concluded that Evolut devices, sold by Medtronic CoreValve LLC, violate a Colibri patent for replacing heart valves in patients with heart disease.
Medical device maker Medtronic plans to appeal the case.
Reader Comments(0)